Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Tech News Turkmenistan.
Press releases published on May 5, 2025

XMPro MAGS 1.5: Agentic AI for Industry with MCP & A2A Integration
DALLAS, May 05, 2025 (GLOBE NEWSWIRE) -- XMPro today announced the release of Multi-Agent Generative System (MAGS) version 1.5, introducing an advanced trust architecture for industrial AI that establishes new standards for reliability, security, and cross …

WiseCryptoNews Portal Launches While Polymarket Puts XRP ETF Approval Odds at 79%
Dubai, UAE, May 05, 2025 (GLOBE NEWSWIRE) -- WiseCryptoNews has unveiled its platform built to track the most important developments across digital assets, offering readers a clearer view of shifting sentiment in real time. With the The XRP ETF approval …

ProStar Holdings Announces Non-Brokered Private Placement
GRAND JUNCTION, Colo., May 05, 2025 (GLOBE NEWSWIRE) -- (OTCQB: MAPPF) (TSXV: MAPS) (FSE: 5D00) ProStar Holdings Inc. (the "Company" or "ProStar®") a world leader in Precision Mapping Solutions®, is pleased to announce a non-brokered private placement for …

Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, May 05, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that today it has …

Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold a conference call to discuss the …

DBV Technologies participera à la conférence Citizens JMP Life Sciences
Châtillon, France, le 5 mai (22 :30 CEST) 2025 DBV Technologies participera à la conférence Citizens JMP Life Sciences DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), société biopharmaceutique en phase clinique, …

Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update
Announced rosnilimab, a depleter and agonist targeting PD-1+ T cells, achieved positive results in Phase 2b rheumatoid arthritis (RA) trial; to present updated clinical and translational data in the first week of June Initial Phase 2 data for rosnilimab in …

Certara Reports First Quarter 2025 Financial Results
RADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter of fiscal year 2025. First Quarter Highlights: Revenue was $106.0 …

Dogecoin Whales have Accumulated about 100 million DOGE tokens While Trader’s Eyes are on PaladinMining to Earn Massive Returns
London, UK, May 05, 2025 (GLOBE NEWSWIRE) -- Dogecoin continues to show bullish signals while 100 million DOGE tokens accumulated by the whales have further strengthened it – making it highly desirable for traders. As Crypto analysts suggest a price surge …

Aterian Sets Date for First Quarter 2025 Earnings Announcement & Investor Conference Call
SUMMIT, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Aterian, Inc. (Nasdaq: ATER) (“Aterian” or the “Company”), a technology-enabled consumer products company, today announced that it will issue its financial results for the first quarter ended March 31, 2025 on …

Shoals Technologies Group, UGT Renewables and Sun Africa Announce Collaboration on up to 12GW of Solar Projects
PORTLAND, Tenn., May 05, 2025 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (Nasdaq: SHLS), a global leader in electrical balance of system (EBOS) solutions for the energy transition market, announced today the execution of a Memorandum of …

Context Therapeutics Announces Chief Medical Officer Transition
PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced Dr. Karen Smith, …

Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate Updates
Cash runway extended into 2029 Initiation of Phase 3 ReDiscover-2 trial on track for mid-2025 Initiated Phase 1 RLY-2608 vascular malformations clinical trial in Q1 Extended cash runway expected to fully fund the Company meaningfully past topline data for …

GigaCloud Technology Inc. to Announce First Quarter 2025 Financial Results and Host Conference Call on May 12, 2025
EL MONTE, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc. (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that it will report …

EverQuote Announces First Quarter 2025 Financial Results
First Quarter Revenue Growth of 83% Year-Over-Year to $166.6 million First Quarter Variable Marketing Dollars Increase of 52% Year-Over-Year to $46.9 million Delivers First Quarter Net Income of $8.0 million and Record Adjusted EBITDA of $22.5 million …

Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights
Company Announces Strategic Realignment to Focus on Core Programs and Extend Cash Runway Icovamenib progressing toward the next phase of clinical development in insulin deficient type 2 diabetes patients and patients that are currently uncontrolled on a …

Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results
MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the …

ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates
Announced focused registrational clinical development plans for lead programs, extended cash runway, and accelerated/augmented corporate milestones Presented preclinical data supporting potential best-in-class profile of ORIC-944 in combination with AR …

uniQure to Announce First Quarter 2025 Financial Results
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, May 05, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs will report first quarter 2025 financial …

AvePoint to Participate in May Investor Conferences
JERSEY CITY, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT), the global leader in data security, governance and resilience, today announced that members of the Company’s executive management team will present at the following investor …